| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 9 | 2011 | 524 | 1.120 |
Why?
|
| Thioredoxins | 3 | 2010 | 26 | 0.950 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2008 | 197 | 0.830 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 532 | 0.750 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2013 | 701 | 0.710 |
Why?
|
| Up-Regulation | 9 | 2011 | 914 | 0.690 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2010 | 128 | 0.680 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 390 | 0.670 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2006 | 262 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 512 | 0.580 |
Why?
|
| Aorta | 7 | 2017 | 562 | 0.570 |
Why?
|
| Palmitic Acid | 4 | 2010 | 33 | 0.550 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 720 | 0.520 |
Why?
|
| Aortic Aneurysm | 2 | 2017 | 239 | 0.520 |
Why?
|
| Cells, Cultured | 15 | 2012 | 3180 | 0.480 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2013 | 252 | 0.470 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2010 | 16 | 0.460 |
Why?
|
| Endothelial Cells | 6 | 2010 | 539 | 0.450 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 93 | 0.410 |
Why?
|
| Pulmonary Medicine | 1 | 2013 | 26 | 0.400 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 125 | 0.370 |
Why?
|
| Insulin | 2 | 2006 | 1260 | 0.350 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 2669 | 0.340 |
Why?
|
| Thrombomodulin | 1 | 2010 | 23 | 0.330 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 252 | 0.330 |
Why?
|
| MAP Kinase Signaling System | 3 | 2006 | 324 | 0.330 |
Why?
|
| Lung Diseases | 1 | 2013 | 406 | 0.310 |
Why?
|
| Metformin | 1 | 2010 | 165 | 0.290 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 182 | 0.280 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 269 | 0.280 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 187 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2009 | 372 | 0.260 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 260 | 0.260 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2012 | 99 | 0.250 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2006 | 139 | 0.250 |
Why?
|
| Aorta, Thoracic | 6 | 2013 | 544 | 0.250 |
Why?
|
| Resistin | 1 | 2006 | 30 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 491 | 0.250 |
Why?
|
| Cell Differentiation | 2 | 2013 | 2043 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2010 | 874 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 1434 | 0.220 |
Why?
|
| Glucose | 1 | 2009 | 926 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 227 | 0.210 |
Why?
|
| Carrier Proteins | 1 | 2009 | 1075 | 0.210 |
Why?
|
| Procollagen-Proline Dioxygenase | 3 | 2008 | 36 | 0.200 |
Why?
|
| Angiotensin II | 2 | 2013 | 173 | 0.190 |
Why?
|
| Blotting, Western | 4 | 2010 | 1138 | 0.190 |
Why?
|
| China | 2 | 2013 | 296 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2010 | 249 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2013 | 4936 | 0.170 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 143 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2013 | 2915 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 433 | 0.150 |
Why?
|
| Humans | 28 | 2017 | 134145 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2012 | 3677 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2012 | 1713 | 0.130 |
Why?
|
| Protein Binding | 2 | 2012 | 1860 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1332 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2006 | 651 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 701 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2012 | 186 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2012 | 4012 | 0.110 |
Why?
|
| Introns | 4 | 2008 | 319 | 0.110 |
Why?
|
| RNA | 2 | 2008 | 607 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 13 | 0.110 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 39 | 0.110 |
Why?
|
| Apoptosis | 3 | 2012 | 1945 | 0.110 |
Why?
|
| Aortitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Elastic Tissue | 1 | 2012 | 19 | 0.100 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2012 | 11 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 112 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 89 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 41 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 103 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 86 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 80 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2012 | 87 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2170 | 0.100 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 205 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 68 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 40 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2013 | 918 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 377 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 31 | 0.090 |
Why?
|
| Collagen Type III | 2 | 2013 | 26 | 0.090 |
Why?
|
| Vasculitis | 1 | 2011 | 51 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 672 | 0.090 |
Why?
|
| Collagen Type I | 2 | 2013 | 129 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 287 | 0.090 |
Why?
|
| Plasmids | 2 | 2009 | 531 | 0.090 |
Why?
|
| Atherosclerosis | 2 | 2011 | 1003 | 0.090 |
Why?
|
| Reference Values | 1 | 2012 | 738 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 385 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 55 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1044 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2010 | 61 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 93 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 21789 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 206 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 24 | 0.080 |
Why?
|
| Transfection | 3 | 2006 | 1098 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 31 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 299 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2009 | 37 | 0.080 |
Why?
|
| Middle Aged | 8 | 2014 | 29395 | 0.080 |
Why?
|
| Octamer Transcription Factors | 1 | 2008 | 9 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2010 | 345 | 0.070 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 21 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2006 | 246 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1764 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 1041 | 0.070 |
Why?
|
| Nucleotides | 1 | 2008 | 96 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 7 | 0.070 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Histones | 2 | 2008 | 572 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3508 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 373 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 2265 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2006 | 19 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1626 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 60 | 0.060 |
Why?
|
| Binding Sites | 2 | 2006 | 1386 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 33 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 65 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 131 | 0.060 |
Why?
|
| Elastin | 1 | 2005 | 31 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 498 | 0.060 |
Why?
|
| Mice | 3 | 2012 | 19043 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2005 | 91 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1735 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1436 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 1407 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 161 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 874 | 0.060 |
Why?
|
| Animals | 5 | 2013 | 36518 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1762 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 623 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 353 | 0.050 |
Why?
|
| Male | 9 | 2014 | 66171 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4881 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 505 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 11184 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 609 | 0.050 |
Why?
|
| Time Factors | 2 | 2014 | 6592 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2006 | 700 | 0.040 |
Why?
|
| Cell Line | 1 | 2006 | 2863 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1538 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 139 | 0.040 |
Why?
|
| Gene Expression | 3 | 2012 | 1622 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 38 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2006 | 2734 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1595 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 718 | 0.030 |
Why?
|
| Female | 7 | 2014 | 72003 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2949 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 13098 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2008 | 838 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 488 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 3876 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 691 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 2177 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 38 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 49 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 102 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 60 | 0.030 |
Why?
|
| ADAMTS1 Protein | 1 | 2012 | 18 | 0.030 |
Why?
|
| ADAMTS4 Protein | 1 | 2012 | 11 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 123 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2013 | 79 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2091 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 111 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 152 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 120 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 230 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 3180 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 55 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 398 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 249 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2013 | 124 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3978 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 337 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 890 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1190 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 67 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 154 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 185 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 625 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 628 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 330 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 710 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 195 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 157 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 472 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 442 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3056 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 18 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2006 | 21 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 67 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 141 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 97 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 139 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 108 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 115 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2562 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 379 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 182 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 168 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 596 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 318 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 399 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3431 | 0.010 |
Why?
|
| Adult | 3 | 2014 | 31943 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4605 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 445 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 790 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 897 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 1148 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 1135 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1685 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2822 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1922 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 7232 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 20643 | 0.000 |
Why?
|